Clinical evaluation of a computer-aided diagnosis system for determining cancer aggressiveness in prostate MRI

OBJECTIVES - To investigate the added value of computer-aided diagnosis (CAD) on the diagnostic accuracy of PIRADS reporting and the assessment of cancer aggressiveness.

METHODS - Multi-parametric MRI and histopathological outcome of MR-guided biopsies of a consecutive set of 130 patients were included. All cases were prospectively PIRADS reported and the reported lesions underwent CAD analysis. Logistic regression combined the CAD prediction and radiologist PIRADS score into a combination score. Receiver-operating characteristic (ROC) analysis and Spearman's correlation coefficient were used to assess the diagnostic accuracy and correlation to cancer grade. Evaluation was performed for discriminating benign lesions from cancer and for discriminating indolent from aggressive lesions.

RESULTS - In total 141 lesions (107 patients) were included for final analysis. The area-under-the-ROC-curve of the combination score was higher than for the PIRADS score of the radiologist (benign vs. cancer, 0.88 vs. 0.81, p = 0.013 and indolent vs. aggressive, 0.88 vs. 0.78, p < 0.01). The combination score correlated significantly stronger with cancer grade (0.69, p = 0.0014) than the individual CAD system or radiologist (0.54 and 0.58).

CONCLUSIONS - Combining CAD prediction and PIRADS into a combination score has the potential to improve diagnostic accuracy. Furthermore, such a combination score has a strong correlation with cancer grade.

KEY POINTS - • Computer-aided diagnosis helps radiologists discriminate benign findings from cancer in prostate MRI. • Combining PIRADS and computer-aided diagnosis improves differentiation between indolent and aggressive cancer. • Adding computer-aided diagnosis to PIRADS increases the correlation coefficient with respect to cancer grade.

Eur Radiol. 2015 Jun 10. [Epub ahead of print]

Litjens GJ1, Barentsz JO, Karssemeijer N, Huisman HJ.

Department of Radiology, Radboud University Medical Center, 766, Postbus 9101, 6500HB, Nijmegen, The Netherlands, .


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.